APOA1 and type 2 diabetes mellitus: Chronic enhancement of HDL cholesterol and APOA-I concentrations over the long term through the inhibition of cholesteryl ester transfer protein (CETP) activity has also been demonstrated to enhance glycemic regulation in individuals with T2DM [219,220].